Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through toll-like receptors. Idera is working on therapeutics for oncology, asthma and allergy, and infectious diseases. Idera Pharmaceuticals serves the healthcare sector in the States of Massachusetts and Pennsylvania.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Idera Pharmaceuticals (IDRA US)

Current report pursuant to Section 13 or 15(d) (PDF)

US SEC Form SC 13D for Idera Pharmaceuticals Inc

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Current report pursuant to Section 13 or 15(d) (PDF)

Current report pursuant to Section 13 or 15(d) (PDF)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Current report pursuant to Section 13 or 15(d) (PDF)

US SEC Form SC 13D for Idera Pharmaceuticals Inc

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Current report pursuant to Section 13 or 15(d) (PDF)

Current report pursuant to Section 13 or 15(d) (PDF)

Statement of changes in beneficial ownership of securities - general instructions (PDF)